FindDrugs.org

Gala Health Anti-Aging / NAD+ Review

Anti-Aging / NAD+ · Reviewed Sep 23, 2026

5.95/10
Gala Health operator trust5.67/10See the full Gala Health brand review
Cash-pay

Our verdict

Gala's longevity line does something this category almost never does: it says on its own page that there is no clinical trial for the compound bundle to cite. NAD+ is offered as a home subcutaneous injection at $199 a month, or $118 on a twelve-month plan, after an asynchronous five-to-seven-minute provider review. What it does not publish is a dose, a pharmacy, or any monitoring beyond a quarterly questionnaire.

Price

from $199/mo

Visit Gala Health

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

Key takeaways

  • $199/month for a 28-day supply, or $118/month on a 12-month plan, published before signup
  • Gala's own page states there is no clinical trial for this compound bundle to cite
  • Framed as intended to support cellular processes — no outcome figure or anti-ageing claim
  • Subcutaneous injection self-administered at home; no dose, concentration or vial size published
  • No pharmacy named and no 503A/503B classification published
  • Up to a 3-month supply per visit with a quarterly async questionnaire; no bloodwork mentioned

What is Gala Health Anti-Aging / NAD+?

NAD+ is one of two compounds in the longevity line of AI Coaching Inc., d/b/a Gala GLP-1. Gala describes it as a coenzyme involved in cellular energy production and DNA repair whose levels decline with age, delivered as a subcutaneous injection the patient gives at home after a licensed provider reviews the intake asynchronously.

Treatment options

Prices as of Sep 23, 2026 — verify current on the brand's site.

Getting started with Gala Health

  1. Complete the online intake — Gala says five to seven minutes
  2. A licensed provider reviews it asynchronously; no video call required
  3. Initial supply ships — one month plus two refills
  4. A quarterly async check-in keeps supply continuing, per Gala

Methodology scorecard

Scored on Sep 23, 2026 under methodology v6

5.95/10
  • Legitimacy & Accreditation
    Critical

    Evidence (as scored Sep 23, 2026): The operating entity is named in the terms of service and the site footer as AI Coaching Inc., d/b/a Gala GLP-1, at a Wilmington, Delaware address, with a support email. No third-party accreditation is claimed anywhere on the site — there is no LegitScript, NABP or pharmacy-accreditation badge — and none was verified. The FDA enforcement register returns no entry for Gala or AI Coaching, and the BBB has no profile under any spelling we tried. — galaglp1.com, Sep 22, 2026

  • Clinical Oversight & Safety
    Critical

    Evidence (as scored Sep 23, 2026): Gala says a state-licensed provider reviews every intake and that medication is prescribed only where a provider judges it appropriate. It states that medical services are delivered by clinicians affiliated with independently owned practices including OpenLoop-affiliated medical groups, and that Gala itself provides administrative, technology and management services and does not provide medical care. No individual clinician is named anywhere on the site. — galaglp1.com, Sep 22, 2026

  • Sourcing Transparency & Legal Context
    High

    Evidence (as scored Sep 23, 2026): We work with a wide network of pharmacies across all 50 states. — FDA drug information — Compounding And FDA Questions And Answers, Sep 16, 2025

  • Data Privacy & Security
    Medium

    Evidence (as scored Sep 23, 2026): A privacy policy is published and the homepage displays a “HIPAA Compliant” badge. The badge is a claim by Gala and is not a certification we can check — HIPAA has no certifying body — so it is recorded as displayed, not as verified. — galaglp1.com, Sep 22, 2026

  • Pricing Transparency & Value
    Critical

    Evidence (as scored Sep 23, 2026): From $199/month 28-day supply, or $118/month on the 12-month plan. Charged at checkout — a licensed provider reviews before anything ships, and if they can't prescribe for you, you're refunded in full. — galaglp1.com, Sep 22, 2026

  • Policy Clarity & Fairness
    High

    Evidence (as scored Sep 23, 2026): The cancellation and refund terms are published in full and are specific. Gala says billing starts when the intake form is completed; that a cancellation request must arrive at least 72 hours before the billing date or the next cycle is charged; that a patient disqualified by its provider receives a full refund; and, in capitals, that in no other event is a refund issued on cancellation. Refunds, where allowed, are limited to the most recent billing cycle. — galaglp1.com, Sep 22, 2026

  • Popularity & Momentum
    Medium

    Evidence (as scored Sep 23, 2026): Gala says it has more than 50,000 patients and its pages carry a Trustpilot mark. We could not verify either figure: trustpilot.com returned HTTP 403 to automated retrieval, and the review counters on Gala's own pages render as zero without client-side scripting, so no rating or volume was readable. The claim is recorded as Gala's and the limit is in gaps. — galaglp1.com, Sep 22, 2026

  • Quality-under-Growth
    Medium

    Evidence (as scored Sep 23, 2026): Nothing adverse is on any public record we could reach: the FDA enforcement register returns no entry for Gala or AI Coaching, and the BBB returns no business profile. Both searches were run with a positive control that discriminates — the same FDA query shape returns entries for MEDVi and Lean Rx. No complaint corpus was reachable, so this records an absence of findings on the registers we can read, not an absence of complaints. — FDA warning-letter register — search for "gala", Sep 22, 2026

  • Access & Speed
    Medium

    Evidence (as scored Sep 23, 2026): Gala publishes its own timings: a five-minute intake for weight loss and a five-to-seven-minute intake for the longevity compounds, an asynchronous provider review with no video call required for longevity, and up to a three-month supply per longevity visit. It says consultations may be synchronous or asynchronous depending on the patient, the state and the medication, and that any video visit is typically only the first session. — galaglp1.com, Sep 22, 2026

  • Transparency & Disclosure
    Critical

    Evidence (as scored Sep 23, 2026): Two things are disclosed well and two are not. Gala labels compounded GLP-1 as not FDA-approved repeatedly and prominently, including in its own pricing footnote and throughout its FAQ, and it publishes BMI thresholds and the labelled contraindications on the drug pages. Against that: it names no compounding pharmacy, saying only that it works with “a wide network of pharmacies across all 50 states”; it names no individual clinician; and its homepage displays the logos of Harvard Medical School, Columbia University Medical Center and Mount Sinai under a line claiming where its doctors trained and practised, with no clinician named and nothing published to check the affiliation against. — FDA drug information — Compounding And FDA Questions And Answers, Sep 16, 2025

  • Support & Care Model
    Supporting

    Evidence (as scored Sep 23, 2026): Gala says provider messaging, dose adjustments and switching between medication kits are included at no extra cost, and that a higher dose carries no additional charge. It advertises 24/7 access to asynchronous provider messaging. — galaglp1.com, Sep 22, 2026

  • Efficacy Honesty
    High

    Evidence (as scored Sep 23, 2026): There's no clinical trial for this compound bundle to cite — so judge us on what's actually different: a licensed provider reviews your intake in minutes, not weeks. — galaglp1.com, Sep 22, 2026

  • Route & Bioavailability Transparency
    Medium

    Evidence (as scored Sep 23, 2026): Subcutaneous injection you take at home — dosing confirmed by your provider — galaglp1.com, Sep 22, 2026

  • Off-Label Menu & Personalization
    Medium

    Evidence (as scored Sep 23, 2026): a licensed provider reads your intake, matches it to the compound and delivery format that fits, and prescribes or follows up with a question — galaglp1.com, Sep 22, 2026

Pricing & cancellation

Visit Gala Health

All-in price

from $199/mo

Cost structure
Subscription. GLP-1 advertised at $179/month on a yearly plan and $199/month on a three-month plan; longevity at $199/month for 28 days or $118/month on a 12-month plan; HRT from $69/month.
Insurance vs. cash
Cash-pay
Deal structure
Cancellation
Cancel any time, but the request must arrive at least 72 hours before the billing date or the next cycle is charged. Billing starts when the intake form is completed.
Forced subscription
Required

Pros & cons

Pros

  • A headline price is published before signup on all three lines, which most of this category does not do
  • GLP-1 eligibility is published before signup at the FDA-labelled thresholds — BMI ≥ 27 with a weight-related condition, or ≥ 30 without
  • Labelled contraindications are published on both GLP-1 drug pages
  • Compounded GLP-1 is labelled not FDA-approved in Gala's own pricing footnote and throughout its FAQ
  • The longevity pages state in Gala's own words that there is no clinical trial for the compound bundle to cite
  • Four HRT routes are offered, including a published non-hormonal path
  • Gala says dose changes, kit switches and provider messaging carry no extra charge

Cons

  • No compounding pharmacy is named on any line, and no 503A or 503B classification is published
  • No individual clinician is named anywhere on the site
  • The homepage displays Harvard, Columbia and Mount Sinai logos under a claim about where its doctors trained, with nothing published to check it against
  • The HRT pages publish four outcome percentages with no source attached
  • The HRT pages never state which regulatory category the hormones fall into — an approved product, or a compounded preparation, though the GLP-1 line is labelled
  • Sermorelin lists elevated IGF-1 as an exclusion but describes no bloodwork that would detect it
  • Billing starts at intake, cancellation requires 72 hours' notice, and outside medical disqualification the published policy is that no refund is issued
  • Two different entry prices are advertised for GLP-1 — $179/month on the homepage and $199/month in the FAQ — on different commitments

Safety

Talk to a licensed clinician

Gala does not publish a side-effect list or a contraindication list for NAD+ on any of the 21 pages we reviewed on 22 September 2026. The page describes what the compound is and how it is taken, and says a licensed provider reviews the intake and confirms dosing, but it does not set out who should not take it or what to watch for. That is a gap a reader should weigh: this is a compounded injectable, it is not FDA-approved, and no dose or concentration is published either. Ask the prescribing clinician directly about interactions and contraindications before starting, and treat the absence of a published list as an absence of published information rather than an absence of risk.

Common side effects

  • Gala does not publish a side-effect list for NAD+ on any page we reviewed

The bottom line

The pricing and the evidence framing are both better than this category's norm. The unknowns are who compounds it, at what dose, and what if anything is monitored beyond a quarterly questionnaire.

Visit Gala Health

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

Frequently asked questions

Does Gala claim NAD+ works?

No. Its longevity page states there is no clinical trial for this compound bundle to cite, and the NAD+ page says supplementation is intended to support the cellular processes that decline with age — a statement of intent rather than of effect.

What does it cost?

$199 a month for a 28-day supply, or $118 a month on a twelve-month plan. Gala says a patient the provider cannot prescribe for is refunded in full.

Is any bloodwork required?

None is mentioned on the page. Gala describes a quarterly asynchronous questionnaire to keep supply continuing, and no baseline or follow-up labs.

Work at Gala Health?

If something here is wrong or out of date, send us a correction request. We read every one and decide what changes — it does not edit the review or move a score.

Sources & how we researched this

Scored on 14 of 14 factors · 10 sources cited

Regulatory

Other

What we couldn't verify

  • Gala names no pharmacy on any of its three lines, saying only that it works with “a wide network of pharmacies across all 50 states” and that ingredients come from FDA-regulated suppliers. No licence number and no 503A or 503B classification appears anywhere on the site. This is an absence on Gala's own pages, confirmed across the homepage, the About FAQ and every product page, not a retrieval failure.
  • Gala says it has more than 50,000 patients and its pages carry a Trustpilot mark. trustpilot.com returned HTTP 403 to automated retrieval on 2026-09-22, and trustpilot.com is recorded `refused` on terms, so no rendered fetch is available either; solving or routing around the block is not a retrieval method this project uses. The counters on Gala's own pages render as zero without client-side scripting, so no rating or volume was readable there. FindDrugs therefore holds no sentiment figure it retrieved itself and publishes none. THIS IS NOT A FINDING THAT THE CLAIM IS FALSE.
  • The federal-docket check ran on 2026-09-21 against the CourtListener REST API v4 (the only sanctioned route — courtlistener.com is refused on terms), with the positive control “Mochi Health” returning 15 records, so the search works. All three queries — “AI Coaching Inc”, “Gala GLP-1” and “Gala Health” — returned records whose case captions contain none of those strings: the matches are case body text about unrelated matters, because the names match ordinary English words. That is TOO GENERIC TO BE EVIDENCE and supports no claim in either direction. There is no measured absence here, and nothing on any Gala page says there is.
  • Gala's homepage displays the three institutions' logos under a line claiming where its doctors trained and practised. No clinician is named anywhere on the site, and nothing is published that would let the affiliation be checked — no name, no credential, no institution-side listing. The claim is recorded as one Gala makes and is not repeated as established anywhere in this review.
  • The page publishes hot flashes resolved at eight weeks, sleep improvement, mood and anxiety relief and bone-loss reduction as percentages, with no source attached to any of them. FindDrugs holds no record for these figures and does not repeat them as findings; they are reported as claims Gala makes.
  • Gala labels its GLP-1 line as not FDA-approved repeatedly and prominently, but the hormone pages carry no equivalent statement. They describe the products as “bioidentical”, which is a marketing term covering both FDA-approved products and compounded preparations, so the question is unresolved on Gala's own pages.
  • Gala's sermorelin page lists elevated prolactin or IGF-1 among the conditions that make the peptide inappropriate, but nothing on the page describes a baseline IGF-1 draw or any bloodwork, and the stated follow-up is a quarterly asynchronous questionnaire. Whether a test happens inside the intake is not published.
  • Gala says licensed providers in all 50 states across each of its three lines. That statement was not verified against state licence records; no such record was retrieved for this review.
Last reviewed Sep 23, 2026 · methodology v6View the ledger

Top pick

Gala Health 5.95/10